Navigation Links
Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months
Date:7/1/2010

through the 69 month period by analysis of lumber spine (LS) and femoral neck (FN) DXA Z-scores.  Four of the patients received bisphosphonates and VPRIV throughout the 69 month period, and 6 were treated with only VPRIV. The study found that BMD improved significantly for the ITT patient population (n=10), and for those who received VPRIV alone (n=6) by months 24 and 33 demonstrating a continuous improvement in BMD among patients for up to 69 months (5.75 years) following dose reductions.

"The data presented provide additional and compelling support that VPRIV is able to provide patients with continuous improvement of key therapeutic goals, including bone, in a clinically meaningful way," said Professor Ari Zimran from the Shaare Zedek Medical Center, Jerusalem, Israel.

TKT-025 EXT BMD Results Highlights Include:

  • Among those treated with VPRIV alone, 3 patients with osteopenia (2 LS and 1 FN) achieved normal BMD and 1 patient with osteoporosis (FN) became osteopenic by 69 months.
  • Among the ITT population, lumbar and femoral BMD improved significantly by months 24 and 33, respectively (LS: 0.39; 95%CI 0.06, 0.72 and FN: 0.39; 95%CI 0.16, 0.62)).
  • At baseline, Z-scores among ITT patients were significantly lower than those seen in age and gender matched controls and showed significant improvement over time during VPRIV treatment (LS and FN p< 0.001 for all measures).
  • Among VPRIV-only treated patients, significant improvement was seen over time [the Z-score LS y-intercept was -1.29 (P= 0.005), LS slope = +0.16/year (P=0.028), FN slope +0.10/year (P=0.006)].

Also presented at the EWGGD were data from a Phase III clinical trial (TKT-034) that demonstrated pati
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 , The ... hub of information concerning the biopharmaceutical Group,s national and international ... addition to the recently launched institutional website that is receiving ... enriched by a new chapter in the fascinating story of ... detailed and panoramic hub on the world of clinical research, ...
(Date:12/17/2014)... 2014 PCCA received the Autism Hope ... ) program seal for best practices in meeting ... medical practices, materials and goods that meet strict ... Children affected by autism often have unique physical ... ingredients found in food and medicine – for ...
(Date:12/15/2014)... Research and Markets , ... has announced the addition of the "Cardiac Guidewires ... their offering. Global Guidewires sector is projected to ... America accounts for nearly 35% (2015) of ... claims approximately 25% (2018). Asia-Pacific ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Amsterdam, June 26, 2008 - Elsevier, the leading ... and services, today announced highlights of its Journal ... Journal Citation Reports published by ThomsonReuters, reports that ... respective categories. In addition, total Elsevier journal citations ...
... to Avastin at Improving Visual Acuity When, Used ... Share, ... Resources, WALTHAM, Mass., June 26 Decision Resources, ... on pharmaceutical and,healthcare issues, finds that Genentech/Novartis,s Lucentis will ...
... One of Canada,s Largest Academic Cancer Centers, ... ARAY ), a global leader in the field ... de Montreal (CHUM),has purchased a CyberKnife(R) Robotic Radiosurgery ... Montreal, Canada., CHUM, one of the largest ...
... Pharmaceuticals, Inc. (Nasdaq: AVRX), announced today the nomination of AVN316 ... Inhibitor program. This novel compound inhibits the Beta-catenin pathway and ... The Company plans to begin clinical testing of AVN316 in ... commonly activated cancer pathways and is known to play a ...
... who eat unhealthy, high-fat meals may experience memory declines ... antioxidant vitamins with the meal, according to new research ... diabetes to cognitive complications in humans. Adults with ... memory deficits after eating unhealthy foods. , This ...
... 2008 Tour Will Donate More than $1.6 Million and ... Dealers Supporting the Fight against Pediatric Cancer, FOUNTAIN ... on Wheels(TM) Tour launched yesterday in Los Angeles with ... Hospital Los,Angeles. The Tour will visit 32 children,s hospitals ...
Cached Medicine News:Health News:Elsevier announces 2007 journal impact factor highlights 2Health News:Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy 2Health News:First CyberKnife System to be Installed in Canada 2Health News:First CyberKnife System to be Installed in Canada 3Health News:First CyberKnife System to be Installed in Canada 4Health News:Avalon Pharmaceuticals names lead development candidate in beta-catenin inhibitor program 2Health News:Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal 2Health News:Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal 3Health News:Hyundai Motor America and Its Dealers Launch National Hope on Wheels Tour to Support Pediatric Cancer Research 2Health News:Hyundai Motor America and Its Dealers Launch National Hope on Wheels Tour to Support Pediatric Cancer Research 3
... management software - was designed by ... improvement tool helps diabetes care providers ... bridges medicine with technology by providing ... information technology product. This diabetes ...
... of diabetes in order to maintain tight control ... way to reduce or even prevent diabetes-related complications. ... a diabetes patients quality of life, however, is ... been the guiding factors in the development of ...
... the CGMS System Gold can assist you ... based on detailed glycemic profiles. Its also ... motivation and collaboration with patients.1, ,While ... all diabetes patients, it may be of ...
... The GlucoWatch G2 Biographer is intended for ... levels in adults (aged 18 and older) ... diabetes. Parents should supervise the use of ... G2 Biographer is intended to supplement, not ...
Medicine Products: